Related Experiment Videos
Rhinocerebral mucormycosis
Abstract:
Mucormycosis is a fulminant fungal infection occurring in debilitated patients with an underlying pathologic condition. The rhinocerebral form of the disease, which comprises nearly one half of recently reported cases, is most often found in uncontrolled diabetics or profoundly dehydrated children. Infection usually begins in the nose and progresses through the paranasal sinuses, invading the orbit and CNS secondarily. Despite the known pathogenesis of this disease, the ophthalmologist is often first to consider the diagnosis, due to inadequate intranasal examination by the primary physician. The delay caused by late occurrence of orbital manifestations has resulted in poor survival rates, despite vigorous therapy. In recent years, increased physician awareness has led to earlier diagnosis of rhinocerebral mucormycosis. This report presents 13 cases with which we have delt since 1963. The long-term survival rate is 85%. Aggressive surgical therapy, with repeated debridement, in combination with intravenous amphotericin B, have led to this high rate of cure.
Insights
Early diagnosis and aggressive treatment of rhinocerebral mucormycosis, a severe fungal infection, significantly improve patient outcomes. This approach, combining surgery and amphotericin B, achieved an 85% long-term survival rate in a recent case series.
Area of Science:
- Mycology
- Infectious Diseases
- Ophthalmology
Background:
- Mucormycosis is a severe fungal infection affecting debilitated individuals.
- The rhinocerebral form is common in uncontrolled diabetics and dehydrated children.
- Delayed diagnosis, often by ophthalmologists, leads to poor outcomes.
Purpose of the Study:
- To report on the management and outcomes of 13 cases of rhinocerebral mucormycosis.
- To highlight the importance of early diagnosis and aggressive treatment.
Main Methods:
- Review of 13 cases of rhinocerebral mucormycosis treated since 1963.
- Aggressive surgical debridement and intravenous amphotericin B therapy.
Main Results:
- The study reports a long-term survival rate of 85%.
- Early diagnosis and prompt, aggressive treatment were associated with improved survival.
Conclusions:
- Aggressive surgical intervention combined with intravenous amphotericin B is effective in treating rhinocerebral mucormycosis.
- Increased physician awareness is crucial for earlier diagnosis and better patient prognosis.